Bharat Biotech’s TB vaccine candidate on the verge of entering phase-III trials Subject: Science and technology Section: Biotechnology Context:  A new Tuberculosis (TB) vaccine candidate of Bharat Biotech International is on the verge of entering phase III clinical trials. Details: Two separate Phase II trials of Mycobacterium Tuberculosis Vaccine (MTBVAC) of Bharat Biotech have been […]